LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Big Super Bowl betting coupled with underdog Eagles win to boost DraftKings bottom line, says Bank of America

Chaim Potok by Chaim Potok
February 12, 2025
in Investing
Big Super Bowl betting coupled with underdog Eagles win to boost DraftKings bottom line, says Bank of America
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


Sports betting company Draftkings could see strong gains ahead thanks to this year’s Super Bowl betting activity and the Philadelphia Eagles’ victory, according to Bank of America. Compared to last year’s Super Bowl, both FanDuel and New Jersey’s Division of Gaming Enforcement reported a 19% gain in wagering, and GeoComply reported a 14% increase in activity. Analyst Shaun Kelley said that Draftkings, whose shares have risen only around 0.5% over the past 12 months, might be poised to benefit as a result. He expect the company to bring in an additional $20 million to $25 million in EBITDA year on year. “We think the ability to grow double-digits during the biggest event of the year is impressive and could help assuage concerns of slowing handle,” Kelley wrote in a Wednesday note. “In addition to the strong handle growth, we think the books benefitted from the Eagles winning and key players including Saquon Barkley and Travis Kelce staying out of the endzone.” This comes as the company has already seen an acceleration in handle growth in the beginning of 2025. The bank noted that DraftKings’ handle, which represents the amount of money wagered in specific events, went up by an average of 19% in January. That said, Kelley doesn’t believe Draftkings will raise its 2025 guidance to reflect its strong start to the year. “We think DKNG could face > $100M of annualized headwinds from higher taxes in Maryland and Ohio and launch costs in Missouri that are not currently in their 2025 guide,” the analyst also said. “Given regulatory uncertainty, we expect DKNG to reiterate their 2025 guidance and yet factor in specific state tax changes, though they may help quantify or bridge the potential impact.” A majority of analysts on Wall Street are bullish on the name. Out of the 37 analysts covering it, 32 of them have a strong buy or buy rating, while the remaining five have a hold rating, according to LSEG data. Draftkings also has a consensus price target over the next 12 months of nearly $52. That reflects more than 19% upside from Tuesday’s close.



Source link

You might also like

Friday’s big stock stories: What’s likely to move the market in the next trading session

This auto supplier just pivoted to AI data centers. Wall Street is really bullish

How EPA ‘endangerment finding’ repeal could impact your wallet

Share30Tweet19
Previous Post

Realty Income seals £6.5m deal for West Midlands Lidl supermarket | Property Week

Next Post

Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short 

Chaim Potok

Chaim Potok

Recommended For You

Friday’s big stock stories: What’s likely to move the market in the next trading session
Investing

Friday’s big stock stories: What’s likely to move the market in the next trading session

February 13, 2026
This auto supplier just pivoted to AI data centers. Wall Street is really bullish
Investing

This auto supplier just pivoted to AI data centers. Wall Street is really bullish

February 12, 2026
How EPA ‘endangerment finding’ repeal could impact your wallet
Investing

How EPA ‘endangerment finding’ repeal could impact your wallet

February 12, 2026
With the market rotation underway, agribusiness stocks may be ready for a bounce
Investing

With the market rotation underway, agribusiness stocks may be ready for a bounce

February 12, 2026
Next Post
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short 

Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short 

Related News

Gold futures settle at fresh 3-week low

Gold futures settle at fresh 3-week low

September 13, 2023
Detroit is going to power 100% of its municipal buildings with solar

Detroit is going to power 100% of its municipal buildings with solar

June 28, 2023
XRP price flashes classic ‘hidden bullish divergence.’ Is  still in play?

XRP price flashes classic ‘hidden bullish divergence.’ Is $5 still in play?

November 4, 2025

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • jutawantoto
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?